Details for New Drug Application (NDA): 019002
✉ Email this page to a colleague
The generic ingredient in VASCOR is iothalamate meglumine; iothalamate sodium. There is one drug master file entry for this compound. Additional details are available on the iothalamate meglumine; iothalamate sodium profile page.
Summary for 019002
Tradename: | VASCOR |
Applicant: | Johnson And Johnson |
Ingredient: | bepridil hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019002
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Dec 28, 1990 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Dec 28, 1990 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Dec 28, 1990 | TE: | RLD: | No |
Expired US Patents for NDA 019002
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-001 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-003 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-002 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription